ABERA — Abera Bioscience AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Abera Bioscience AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	C2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	SAS	SAS	SAS	SAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	2.65	0.902	12	15.4	3.32
Net Total Receivables	0.347	0.175	0.295	0.766	0.765
Prepaid Expenses
Total Other Current Assets
Total Current Assets	3	1.08	29.5	17.7	7.46
Net Intangible Assets
Total Assets	4.89	2.97	31.4	19.6	9.35
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.816	2.54	2.22	2.8	3.69
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	0.816	2.54	2.22	2.8	3.69
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	4.07	0.428	29.2	16.8	5.66
Total Liabilities & Shareholders' Equity	4.89	2.97	31.4	19.6	9.35
Total Common Shares Outstanding